One of the most chal­lenging aspects of treating patients with ALS, or Lou Gehrig’€™s dis­ease, is fig­uring out whether the treat­ments are working at all. That’s because patients are often too weak to endure the strength and breathing tests that mea­sure the dete­ri­o­ra­tion of their muscle function.

Read the article at Boston Magazine →